FDA Grants Approval for Prucalopride Succinate ANDA219234 by Alembic
The FDA has granted approval for Alembic's Abbreviated New Drug Application for Prucalopride Succinate.
Asset / Drug
Drug and asset intelligence for Prucalopride with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.